NAPSRx CNPR Exam: Key Concepts and Questions
with 100% Correct Answers | Verified | Latest Update
2025!!
a drug needed immediately and given only once - (ANSWER)STAT order
signs, symptoms and treatment of acute overdoses - (ANSWER)Overdosage
section of labeling
duplication, opposition (antagonism) and alteration - (ANSWER)Types of drug-
drug interactions
tolerance is the diminished response to a drug; resistance is the cells ability to
resist the effects of the drug on them. - (ANSWER)Tolerance vs Resistance
the process by which applicants must scientifically demonstrate to the FDA that
their generic product is bioequivalent to or performs in the same way as the
innovator drug, no duplicate testing - (ANSWER)Abbreviated New Drug
Application (ANDA)
A.K.A. Drug Price Competition and Patent Restoration Act; made it easier to bring
generic drugs to the market by requiring the FDA to only look at bioavailability
studies in order to approve an ANDA; gave protection to the research based
manufacturers by providing a 30-month automatic cooling off period once an
ANDA is challenged for patent infringement. - (ANSWER)Hatch-Waxman Act of
1984
,passive diffusion, facilitated diffusion, active transport, and pinocytosis -
(ANSWER)Four basic transport mechanisms
potency: amount of drug necessary to produce desired effect; efficacy: magnitude
of maximal response that can be received from a drug; efficacy is almost always
more important than potency. - (ANSWER)Potency vs Efficacy
phases I-IV - (ANSWER)Four phases of clinical trials
Abstract, Introduction, methods, results, discussion/conclusions - (ANSWER)Key
Parts Of A Clinical Paper
reliability = consistency and validity = accuracy - (ANSWER)Reliability vs Validity
sampling error is unbiased and is randomly chosen from the population; selection
bias is when the sample was specifically chosen based on particular
characteristics. - (ANSWER)Sampling error vs Selection bias
An independent variable is the one that influences the variation. A dependent
variable is the variable being tested and measured in a scientific experiment. -
(ANSWER)Independent vs Dependent variable
involve retrospective monitoring of physicians' prescribing patterns; more than
90% of HMOs require DURs; nowadays mostly monitors cost savings. -
(ANSWER)Drug Utilization Review (DUR) programs
,based on the premise that all resources are scarce, and therefore every time we
choose to use a resource it reduces the possibility of it being used in another way.
- (ANSWER)Opportunity cost
Disease-state or unbranded ads (provides public information on a disease, not a
drug) - (ANSWER)DTC advertising in Europe
company reps can only offer occasional meals as long as they are modest, and
only offered in an office/hospital setting in conjunction with an educational
presentation. - (ANSWER)PhRMA code on meals
p. 268-274 - (ANSWER)FAQ about the PhRMA code
p. 300-301 - (ANSWER)Urology and selling to Urologists
they serve as educators and field-based medical resources; they interface
between their company and healthcare leaders. - (ANSWER)Medical Science
Liaison (MLS)
push-through refers to the company's overall efforts to demonstrate clinical
efficiency and efficacy and cost effectiveness of a product. - (ANSWER)Push
through vs Pull through sales strategies
, generates demand for the product, usually in ways consistent with the health
plans goals and guidelines. - (ANSWER)pull-through
the ability of an indicator to correctly predict an outcome. - (ANSWER)predictive
validity
*the size of the target patient population, the chronicity of the disease state, the
relevance of that disease state to its sufferers, the avg value of a patient taking
medication. - (ANSWER)criteria for mass advertising in pharmaceutical marketing
conference sponsors should accept subsidies for continuing medical education
conferences. - (ANSWER)AMA guidelines on subsidies
the physician. - (ANSWER)decision maker in pharmaceutical sales
drugs approved for serious or life-threatening conditions. - (ANSWER)fast track
drugs
the amount that the manufacturer of a drug pays to an insurer or health plan for
each unit of drug dispensed. - (ANSWER)rebate
a drug identical to a brand-name drug in various aspects. - (ANSWER)generic drug
with 100% Correct Answers | Verified | Latest Update
2025!!
a drug needed immediately and given only once - (ANSWER)STAT order
signs, symptoms and treatment of acute overdoses - (ANSWER)Overdosage
section of labeling
duplication, opposition (antagonism) and alteration - (ANSWER)Types of drug-
drug interactions
tolerance is the diminished response to a drug; resistance is the cells ability to
resist the effects of the drug on them. - (ANSWER)Tolerance vs Resistance
the process by which applicants must scientifically demonstrate to the FDA that
their generic product is bioequivalent to or performs in the same way as the
innovator drug, no duplicate testing - (ANSWER)Abbreviated New Drug
Application (ANDA)
A.K.A. Drug Price Competition and Patent Restoration Act; made it easier to bring
generic drugs to the market by requiring the FDA to only look at bioavailability
studies in order to approve an ANDA; gave protection to the research based
manufacturers by providing a 30-month automatic cooling off period once an
ANDA is challenged for patent infringement. - (ANSWER)Hatch-Waxman Act of
1984
,passive diffusion, facilitated diffusion, active transport, and pinocytosis -
(ANSWER)Four basic transport mechanisms
potency: amount of drug necessary to produce desired effect; efficacy: magnitude
of maximal response that can be received from a drug; efficacy is almost always
more important than potency. - (ANSWER)Potency vs Efficacy
phases I-IV - (ANSWER)Four phases of clinical trials
Abstract, Introduction, methods, results, discussion/conclusions - (ANSWER)Key
Parts Of A Clinical Paper
reliability = consistency and validity = accuracy - (ANSWER)Reliability vs Validity
sampling error is unbiased and is randomly chosen from the population; selection
bias is when the sample was specifically chosen based on particular
characteristics. - (ANSWER)Sampling error vs Selection bias
An independent variable is the one that influences the variation. A dependent
variable is the variable being tested and measured in a scientific experiment. -
(ANSWER)Independent vs Dependent variable
involve retrospective monitoring of physicians' prescribing patterns; more than
90% of HMOs require DURs; nowadays mostly monitors cost savings. -
(ANSWER)Drug Utilization Review (DUR) programs
,based on the premise that all resources are scarce, and therefore every time we
choose to use a resource it reduces the possibility of it being used in another way.
- (ANSWER)Opportunity cost
Disease-state or unbranded ads (provides public information on a disease, not a
drug) - (ANSWER)DTC advertising in Europe
company reps can only offer occasional meals as long as they are modest, and
only offered in an office/hospital setting in conjunction with an educational
presentation. - (ANSWER)PhRMA code on meals
p. 268-274 - (ANSWER)FAQ about the PhRMA code
p. 300-301 - (ANSWER)Urology and selling to Urologists
they serve as educators and field-based medical resources; they interface
between their company and healthcare leaders. - (ANSWER)Medical Science
Liaison (MLS)
push-through refers to the company's overall efforts to demonstrate clinical
efficiency and efficacy and cost effectiveness of a product. - (ANSWER)Push
through vs Pull through sales strategies
, generates demand for the product, usually in ways consistent with the health
plans goals and guidelines. - (ANSWER)pull-through
the ability of an indicator to correctly predict an outcome. - (ANSWER)predictive
validity
*the size of the target patient population, the chronicity of the disease state, the
relevance of that disease state to its sufferers, the avg value of a patient taking
medication. - (ANSWER)criteria for mass advertising in pharmaceutical marketing
conference sponsors should accept subsidies for continuing medical education
conferences. - (ANSWER)AMA guidelines on subsidies
the physician. - (ANSWER)decision maker in pharmaceutical sales
drugs approved for serious or life-threatening conditions. - (ANSWER)fast track
drugs
the amount that the manufacturer of a drug pays to an insurer or health plan for
each unit of drug dispensed. - (ANSWER)rebate
a drug identical to a brand-name drug in various aspects. - (ANSWER)generic drug
